Top 5 Finance Angel Investors in Isle of Man in January 2026

Last updated: Jan 2026 A list of 5 angel investors that invest in Finance startups based in Isle of man. We rank investors based on the number of investments they made in Finance companies from Isle of man. We update this investor list every month.

Top 5 Finance Angel Investors in Isle of Man in January 2026

Investor	Finance Isle of Man investments
Chris Adelsbach	1
Stuart Gardner	1
Will Neale	1
Charles Delingpole	1
Tom James	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Chris Adelsbach - Founding Partner @ Outrun Ventures

Investment focus

FinTech, Financial Services, Software
Seed, Pre-Seed, Series A
United Kingdom, United States, Ireland

Portfolio highlights

Bourn — Bourn's technology is designed to automate cash flow management, offering SMEs fast access to capital.
Capsa AI — Providing next-generation investors with a competitive edge.
Embed — The regulated Payments Platform unifying crypto and fiat rails. Fung has launched early beta. Sign up to secure your spot.

Stuart Gardner

Investment focus

Financial Services, Funding Platform, Solar
Pre-Seed, Seed, Angel
United Kingdom, United States, Isle of Man

Portfolio highlights

Fundably — Fundably - Get The Right UK Business Loan | Access £1k-£2m
MONET — Embedded finance for agencies and B2B platforms. Frictionless access to white-labelling B2B credit, global payments and new revenue streams. Offer white-label invoice finance to your network, driving growth for you and your suppliers.
VIAN Therapeutics — VIAN Therapeutics is an early-stage biotechnology company focused on transforming retinal disease treatment. With a first-in-class, non-invasive eyedrop as its lead product, VIAN aims to replace invasive injections for conditions like age-related macular degeneration (AMD) and diabetic macular edema (DME). Backed by strong preclinical data andongoing clinical testing, VIAN is positioned to address significant unmet medical needs and disrupt the $15 billion retinal disease market.

Founder (Grabyo, Fonix). Investor.

Investment focus

FinTech, Financial Services, Software
Seed, Pre-Seed, Funding Round
United Kingdom, Italy, Japan

Portfolio highlights

qomodo — Qomodo: La piattaforma BNPL innovativa. Rate a tasso zero, approvazioni veloci, transazioni sicure. Rivoluzionaria nell'acquisto per aziende e consumatori.
Verisian — Verisian accelerates drug time to market with the industry's first platform offering real study traceability (CDISC, SDTM, ADaM, TFLs)
SAPI — SAPI builds credit products for payment companies to facilitate payment flows, engage and retain merchants, and generate new revenue.

Charles Delingpole is Founder and CEO of ComplyAdvantage, a technology company focused on wiping out financial crime using Machine Learning. As CEO, Charles leads the product development and growth of the company. His passion for the issue came from his time as the MLRO of a previous startup he founded when he realized how inefficient processesaround money laundering are. Charles previously worked at The Student Room as a Founder and CEO. He attended the University of Cambridge and The London School of Economics and Political Science (LSE).Over 99% of money laundering is successful, ComplyAdvantage is working to stop it completely. Founded in 2014 with offices in London, New York, Singapore, and Cluj, ComplyAdvantage work with over 350 firms across 45 countries. Charles set up his first company, The Student Room Group, now the world’s largest student discussion forum when he was 16. After completing his MA in Politics at Trinity College Cambridge, and then an MSc in Management, Strategy, and Finance from the LSE, he became an associate at J.P. Morgan Cazenove.